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Abstract 
Background: Since the structure of proteins is more conserved than the sequence, the identification of conserved 
three‑dimensional (3D) patterns among a set of proteins, can be important for protein function prediction, protein 
clustering, drug discovery and the establishment of evolutionary relationships. Thus, several computational applica‑
tions to identify, describe and compare 3D patterns (or motifs) have been developed. Often, these tools consider a 
3D pattern as that described by the residues surrounding co‑crystallized/docked ligands available from X‑ray crys‑
tal structures or homology models. Nevertheless, many of the protein structures stored in public databases do not 
provide information about the location and characteristics of ligand binding sites and/or other important 3D patterns 
such as allosteric sites, enzyme‑cofactor interaction motifs, etc. This makes necessary the development of new ligand‑
independent methods to search and compare 3D patterns in all available protein structures.
Results: Here we introduce Geomfinder, an intuitive, flexible, alignment‑free and ligand‑independent web server for 
detailed estimation of similarities between all pairs of 3D patterns detected in any two given protein structures. We 
used around 1100 protein structures to form pairs of proteins which were assessed with Geomfinder. In these analy‑
ses each protein was considered in only one pair (e.g. in a subset of 100 different proteins, 50 pairs of proteins can be 
defined). Thus: (a) Geomfinder detected identical pairs of 3D patterns in a series of monoamine oxidase‑B structures, 
which corresponded to the effectively similar ligand binding sites at these proteins; (b) we identified structural simi‑
larities among pairs of protein structures which are targets of compounds such as acarbose, benzamidine, adenosine 
triphosphate and pyridoxal phosphate; these similar 3D patterns are not detected using sequence‑based methods; 
(c) the detailed evaluation of three specific cases showed the versatility of Geomfinder, which was able to discriminate 
between similar and different 3D patterns related to binding sites of common substrates in a range of diverse proteins.
Conclusions: Geomfinder allows detecting similar 3D patterns between any two pair of protein structures, regard‑
less of the divergency among their amino acids sequences. Although the software is not intended for simultaneous 
multiple comparisons in a large number of proteins, it can be particularly useful in cases such as the structure‑based 
design of multitarget drugs, where a detailed analysis of 3D patterns similarities between a few selected protein 
targets is essential.
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Background
Current approaches for protein function prediction as 
well as for protein clustering and classification, are based 
on the use of both sequence and/or structural informa-
tion [1, 2]. Nevertheless, considering that the structure 
of proteins is several times more conserved than their 
sequences [3], it is increasingly recognized that methods 
based on structural data can be more informative for the 
aforementioned purposes. In addition, the identification 
of conserved three-dimensional (3D) patterns among a 
set of proteins (related or not between them), could rep-
resent a key event on the structural convergent evolution 
of the queried proteins. Moreover, as in some cases these 
3D patterns can be part of the binding/catalytic sites of 
the proteins, the identification of their characteristics and 
the assessment of their similarities can be useful for the 
development of new lead compounds and the rational 
design of polypharmacological drugs [2, 4–6]. It should 
be noted that in many cases functionally relevant struc-
tural motifs such as catalytic sites or ligand-binding sites 
occur only once in a protein structure. Nevertheless, a 
number of other important 3D patterns such as allosteric 
sites, protein-protein interaction motifs or ion binding 
sites might occur several times in a given protein. For 
instance, numerous allosteric sites have been identified in 
G protein-coupled receptors [7]. Indeed, computational 
mapping in muscarinic receptors has revealed the exist-
ence of up to seven allosteric sites [8]. A similar situation 
is observed in ligand-gated ion channels (e.g. nicotinic 
acethylcholine receptors; [9, 10]) which contain allosteric 
binding sites in their extracellular, transmembrane and 
intracellular domains. Likewise, protein-protein or lipid-
protein interactions can be founded in the occurrence of 
numerous distinct interfaces in the interacting protein(s) 
[11, 12].
This background has motivated the development of 
several computational applications to identify, describe 
and compare 3D patterns (or motifs) (e.g [13–18]), some 
of which are specifically focused on protein ligand-
binding sites (see [19–22] for reviews). Most of these 
approaches implicate the estimation of a scoring func-
tion, based on the comparison of geometric, energetic, 
sequence-based or chemical features of known motifs 
or binding sites. Thus, parameters such as the solvent-
accessible area, Van der Waals and electrostatic energies 
and sequence similarity, have been widely used [23–29]. 
These approaches have proved to be useful for protein 
clustering, drug repurposing, protein classification, drug 
discovery and the establishment of evolutionary relation-
ships [30–34].
Often, these methodologies consider 3D patterns as: (a) 
those described by the residues surrounding co-crystal-
lized ligands/ions available from X-ray crystal structures, 
and b) those identified by sequence-based methods (e.g. 
PROSITE consensus patterns; [35]). Nevertheless, nearly 
30 % of the protein structures stored in the Protein Data 
Bank (PDB)[36], do not provide information about the 
exact location of their ligand binding sites [37]. Indeed, 
even in those cases where these data exist (for both, 
sequence and structural patterns), they usually refer to 
the orthosteric site, but do not consider allosteric sites 
which have been shown to be fundamental for protein 
function and drug design [10, 38]. Additionally, more 
than 3 million of protein homology models have been 
deposited in public databases [39], and in many cases 
they neither offer data about the putative ligand-binding 
sites. This scenery makes necessary the development of 
new ligand-independent methods in order to allow in-
depth assessment of unknown 3D patterns in all available 
protein structures.
Here we introduce Geomfinder, an intuitive, flexible, 
alignment-free and ligand-independent web server for 
an exhaustive searching of similarities among pairs of 
3D patterns detected in two given protein structures 
(X-ray or homology models). Remarkably, our soft-
ware works regardless of the previous existence of 
information about the presence of ligands/ions, motif 
and/or binding site characteristics at the investigated 
proteins.
Implementation
Geomfinder is a free access web-based application that 
estimates the similarity between all possible 3D patterns 
contained in any given pair of protein structures (e.g. 
protein A and protein B). These patterns are represented 
as a set of residues located at certain distances (defined 
by the user) between them. This application is composed 
of four main steps:
The first step generates on each protein a virtual grid 
of coordinates which represents the initial location to 
find the 3D patterns and it is constructed as follows:
  • All coordinates of the geometrical center of the side 
chain of the residues located at a user-defined dis-
tance (radius) are selected (Fig. 1a).
  • The distances between each pair of the previously 
selected coordinates are individually calculated 
(Fig. 1b).
  • The middle point between all measured distances is 
calculated (Fig. 1c).
  • A virtual grid is defined with all middle points coor-
dinates (Fig. 1d).
In the second step all possible 3D patterns occurring 
in each of the proteins of interest are detected, using as 
reference the virtual grid already generated.
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The third step generates a list of four descriptors for 
each 3D pattern identified (described in the next section).
The fourth step makes use of the descriptors previ-
ously estimated to calculate a single similarity score 
among any possible pair of 3D patterns found in each 
queried protein. This is done in an all-against-all proce-
dure, and finally generates a list of pairs of 3D patterns, 
shown as interactive data tables and a Jmol viewer.
3D patterns identification
To identify all 3D patterns in each tested protein, the user 
must define the next parameters:
Grid Radius (Gr): value defined in Å utilized to con-
struct the virtual grid of referential coordinates (Fig. 1). 
A high value of Gr, will imply a high amount of referen-
tial coordinates in the virtual grid. Thus, the higher the Gr 
value, the more detailed is the exploration of patterns in 
the proteins (see an example in Table 2).
Near Threshold (Nt): To form a 3D pattern, each resi-
due must be at least Nt Å away from a same coordinate of 
reference in the virtual grid.
Far Threshold (Ft): To form a 3D pattern, each residue 
must be at most Ft Å away from any other.
Hence, Nt and Ft can be perceived as the dimensional 
limits of the 3D patterns that are being unveiled. Briefly, if 
a small value for Nt is defined, the detected patterns will 
include residues that are very close between them. On the 
contrary, if a higher value for Nt is defined, the identified 
patterns will only include residues that are relatively away 
from each other. The value of Ft represents the maximal 
distance from the virtual coordinate in which a 3D pat-
tern will be searched, and therefore defines the maximal 
size of the pattern.
The values of all these parameters, defined by the user, 
will depend on the aims of the analysis that is being devel-
oped. For instance, if the user is interested in searching 
3D patterns that could serve as drug binding sites, the Nt 
and Ft values should be such that they define a cavity vol-
ume that allows to allocate a molecule of a given size. On 
the other hand, the Gr value will determine how detailed 
the characterization of such pattern will be done (see an 
example in the Additional file 1: Figure S1).
Once the finding of the 3D patterns is completed, the 
following four descriptors are calculated as it is shown in 
the Fig. 2:
Distance (Dist): list of distances between the geomet-
ric centers of the side chains of all the residues form-
ing the 3D pattern. Each distance is stored as a number 
and a pair of letters identifying amino acids (i.e. R5L, 
where R is Arginine, L is Leucine and 5 is the distance 
in Å between them). Finally, each 3D pattern will be 
Fig. 1 Virtual grid of reference coordinates. This figure shows the process to build a grid of reference coordinates
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described by n(n− 1)/2 terms (where n is the number 
of residues of the 3D pattern). A similar descriptor has 
been developed in the algorithm Pocketmatch, where 
the distances between all residues of each ligand-
binding site, measured from three coordinates on the 
aminoacids, are utilized to calculate the similarity 
(PMScore) [40].
Non-bonded Energy (NbE): sum of the short and 
medium range of non-bonded energy of each residue 
forming the 3D pattern. These physicho-chemical 
properties were obtained from published data [41]. 
This type of descriptors have been implemented in the 
FLAP algorithm [42] in which, through the use of the 
GRID force field [43], the similarity of binding sites 
in a pair of proteins, is measured based on the non-
bonded energies defined by the Lennard-Jones and 
Coulomb interactions.
Sequence component (Sc): List of residues forming a 3D 
pattern. Each residue is tagged into a category defined 
as: A: Aliphatic (Glycine, Alanine, Valine, Leucine, Iso-
leucine), B: Aromatic (Phenylalanine, Tyrosine, Tryp-
tophan), C: OH- (Serine, Threonine), D: Acidic (Aspar-
tic Acid, Glutamic Acid), E: Acid amide (Aspargine, 
Glutamine), F: Basic (Arginine, Lysine, Histidine), G: 
Sulphur (Cysteine, Methionine) and H: Cyclic (Pro-
line). This sequence order-independent approach has 
been proposed as an efficient form to detect evolu-
tionary relationships [34].
Perimeter (Tsp): list of distances constituting the short-
est pathway necessary to go over all the residues lin-
ing the 3D pattern. Here the travelling salesman 
problem algorithm [44] is implemented, and each 
distance forming the perimeter is stored as a number 
and a pair of letters identifying amino acids (i.e. R5L, 
where R is Arginine, L is Leucine and 5 is the distance 
in Å between them). Finally, each 3D pattern will be 
described by n terms (where n is the number of resi-
dues of the 3D pattern). Even though this approach 
has not been used before to find similar binding sites 
or patterns, it has been proposed as a competent 
methodology to clusterize and detect similar folds of 
protein structures [45].
Scoring measurements
All pairs of 3D patterns identified in the two tested pro-
teins are compared using an all-versus-all approach. 
Thus, at the end of the analysis each pair of 3D pattern 
has a final similarity score (GScore). If this GScore is 
higher that the threshold defined by the user, the ID of 
both 3D patterns composing each pair, are linked and 
stored as a python list element. The GScore is defined as 
a combination of the similarities (S) of the four descrip-
tors previously mentioned, as stated in the following 
equation:
(1)GScore = SDist ∗ Dp + SNbE ∗ Cp + STsp ∗ Tp + SSc ∗ Sp
Fig. 2 Four descriptors calculated from each 3D pattern. As an example, a 3D pattern is shown in licorice format. Different colors denotes different 
residues (red Asp, orange Leu, pink: Ile and violet Tyr). Squares in segmented lines, show each descriptor obtained from this example of 3D pattern
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In the equation 1, Dp, Cp, Tp and Sp are parameters of 
Geomfinder that represent the relative contributions 
of partial similarities of the distance, the non-bonded 
energy, the perimeter and the sequence component, 
respectively. These parameters must sum 100 % and are 
set at 25  % by default (same contribution of each par-
tial similarity to the GScore). If the user is interested in 
detecting similar 3D patters prioritizing some of these 
features, for example the non-bonded energies, the rela-
tive contribution of each of them can be changed (e.g. 
Cp = 100 %, Dp = Tp = Sp = 0 %; see the Eq. 1).
The terms, SDist, SNbE, STsp and SSc, represent the 
partial similarity associated with each specific descrip-
tor. These similarity values are calculated as the relative 
changes in each property, according to the following 
equations:
where DistA,B, NbEA,B, TspA,B and ScA,B are the respec-
tive data sets or values previously determined for each 
pair of 3D patterns compared (sub-indices A and B, rep-
resent protein A or B). The “|” symbol is used to denote 
cardinality.
It should be noted that GScore gives a quantification 
of similar features that are found between two 3D pat-
terns (e.g. a GScore of 100  % represents identical pat-
terns, whereas 0 % denotes that no similar features exist 
between the two patterns analyzed). Thus, the GScore is 
not intended to determine a threshold from which one 
can establish if two patterns are similar or dissimilar. 
Instead, it quantifies how similar they are. Therefore the 
GScore significance will depend on the research ques-
tion that is being addressed. For instance, in the case of 
two proteins belonging to the same family and showing 
very similar global folds, a GScore of 70 % for a given pair 
of patterns could implicate that such patterns might be 
exploited for the search of ligands able to discriminate 
between both proteins. On the other hand, in the case of 
two completely different proteins, the same GScore value 
could denote a pair of 3D patterns that might be helpful 
for the discovery of common ligands.
System architecture
The architecture of the solution and the essential com-













divided into three main items: the presentation layer, the 
domain layer and the data layer. The presentation layer 
corresponds to the user’s view, and provides the inputs 
to the domain layer. It consists of two modules: first, 
“ParametersView”, which allows the user to enter the 
necessary data to compute the similarity request (PDB 
files and general parameters). The second module is the 
“ResultView”, which gives the results of the compari-
son to the user. These results are divided into two main 
views: the similarities scores of each pair of 3D patterns 
(“TableView”) and the visualization of the protein and/or 
the 3D pattern structures (“ProteinView”). The domain 
layer represents the core of Geomfinder and denotes the 
communication link between the presentation and data 
layers. The primary components are: GetPDB, PDBProc-
ess, PDBMaker and CompareService (from top to bot-
tom). GetPDB is responsible for getting the PDB files 
from two possible different sources: PDB files (for homol-
ogy models) or PDBids (for crystal structures), which 
are provided by the user. Next, it uploads the files to the 
server or retrieves the structures from the Protein Data 
Bank [36]. The PDBprocess module, processes the PDB 
files from the data layer (previously stored on the server 
by GetPDB) finding all 3D patterns which are in accord-
ance with the parameters set by the user. As a result, this 
module generates a list of 3D patterns detected in each 
PDB file. Additionally, this module interacts with the 
PDBMaker to generate and save a PDB file in the data 
layer (this process is carried out for each of the identi-
fied 3D patterns). This module has been optimized using 
python-based multithreading implementation. The Com-
pare-Service receives the lists of 3D patterns generated by 
the PDBprocess module. With these lists, all similarities 
scores are calculated, taking into account the parameters 
provided by the user (ParametersView). In addition, this 
module generates a file in Json format from the filtered 
results. Finally, the data layer stores all the files that have 
been generated in the comparison process.
Results and discussion
General evaluation
To evaluate the performance of Geomfinder, a set of 1100 
protein structures were obtained from the PDB. Several 
measurements of partial structure similarity were done 
with different subsets of proteins. Although in most of 
the following cases we focused on the analysis of ligand-
binding sites, it should be noted that many other pairs 
of 3D patterns could be studied. In the examples ana-
lyzed below, the pairs of proteins assessed were selected 
arbitrarily and each protein was considered in only one 
pair (e.g. in a subset of 100 different proteins, 50 pairs of 
proteins can be defined). All the comparisons done with 
Geomfinder, for the different pairs of protein structures 
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considered, are shown in the corresponding following 
figures.
In all evaluations, a filter of GScore value of 50 % was 
utilized (i.e. only the pairs of 3D patterns with a GScore 
higher than 50 % were considered in the analyses).
Structures of the human enzyme Monoamine Oxidase B
Our first evaluation was done with 38 crystallographic 
structures of the human Monoamine Oxidase-B (MAO-
B; Additional file 2: Table S1). This enzyme is located in 
the mitochondrial outer membrane and catalyzes the 
oxidative deamination of biogenic and xenobiotic amines 
[46]. In all structures available, MAO-B has a co-factor 
flavin-adenine-dinucleotide (FAD) covalently bound 
and its location is the reference for a conserved cata-
lytic binding site in this family of proteins [47]. Several 
compounds which differ in their pharmacodynamics and 
structure have been co-crystallized with MAO-B (e.g. 
1,4-Diphenyl-2-butene, Isatin, n-Propargyl-1(s)-aminoin-
dan, (3R)-3-(prop-2-ynylamino)-2,3-dihydro-1H-inden-
5-ol, among others). These differences generate distinct 
biological responses such as the reversible or the irre-
versible inhibition of the enzyme. In our tests, Geom-
finder was able to detect identical pairs of 3D patterns 
(pairs of 3D patterns with a GScore = 100  %) corre-
sponding to the ligand binding sites of all MAO-B struc-
tures (Fig. 4). Since the pairs compared involved the same 
protein co-crystallized with different inhibitors (Addi-
tional file 1: Figure S3), it was not surprising that a high 
degree of similarity was also found using either global 
sequence or ligand-independent alignment methods. 
Thus, a 100 % of similarity was identified with both, the 
pairwise alignment algorithm of Smith-Waterman imple-
mented on the EMBOSS Website [48] and the CLICK 
software [49]. Noteworthy, the same performance was 
not attained using methods, such as PocketMatch [40], 
which consider the structure of the ligands as the starting 
point to calculate a similarity score (Fig.  4). Hence, our 
results confirm the suitability of Geomfinder to recog-
nize, in spite of the presence or absence of ligands, simi-
lar 3D patterns (in this case ligand-binding sites) that are 
effectively similar or identical.
Protein structure targets of alpha‑acarbose (ACR)
ACR is an anti-diabetic drug used to treat type 2 diabetes 
mellitus [50]. Its structure corresponds to an oligosaccha-
ride of 5 cyclic units and has been co-crystallized in more 
than 20 diverse proteins such as glucoamylase II, GacH 
receptor, glucodextranase, glycoside hydrolase, amylo-
maltase, among others. Recently ACR has been men-
tioned as one of the most promiscuous drugs available in 
the market, and its protein-drug interaction analysis has 
shown the occurrence of six distinct conformers, which 
is reflected in 5 clusters of different structural conforma-
tions. At the sequence level, more diversity is found and 
12 clusters were described [37]. Despite this heterogene-
ity, Geomfinder was able to detect GScore values higher 
than 50 % when comparing 3D patterns contained within 
Fig. 3 Implemented architecture and essential components and services. The architecture consists of three main layers: the presentation, domain 
and data layers, representing the interaction between the essential components of the solution
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ACR binding sites in 11 of 13 pairs of proteins evaluated. 
This finding suggest that the promiscuity of ACR is asso-
ciated with the existence of similar 3D patterns occurring 
at the binding sites of the different proteins targeted by 
the drug. This is in agreement with literature evidence 
showing that binding site similarity is a crucial feature 
underlying drug promiscuity [37]. Remarkably, using the 
same threshold value (50  %), CLICK and PocketMatch 
software identified structural similarities in 6 and 3 of the 
13 pairs compared, respectively (Fig. 5). Furthermore we 
used the tools ProBIS [25], MultiBind [51] and SiteEn-
gine [52] to evaluate the two pairs of proteins which did 
not show similar 3D patterns related with the ACR bind-
ing site using Geomfinder (PDBid 1AGM versus 3AIC 
and 1ULV versus 3WEM). As shown in the Table 1, the 
ACR binding sites of these proteins have different amino 
acids composition, 3D orientations and physico-chemical 
properties, confirming the estimations of Geomfinder.
Protein structure targets of benzamidine (BEN), adenosine 
triphosphate (ATP) and pyridoxal phosphate (PLP)
BEN is a reversible competitive inhibitor employed as 
a ligand to prevent proteases degrading the product of 
interest in protein crystallography [53], PLP is the most 
common enzymatic co-factor, being present in a wide 
number of diverse of proteins and organisms [54] and, as 
it is well known, ATP plays a fundamental role in a vast 
amount of chemical reactions in biological systems. Fur-
thermore, these compounds have been co-crystallized 
with hundreds of proteins such as hydrolases, oxidore-
ductases, isomerases, ligases, transmembrane proteins, 
globular proteins, transporters and receptors. In our 
evaluation, we randomly compared 102 protein targets 
of BEN, 234 protein targets of ATP and 674 protein 
targets of PLP (Additional file 2: Table S1). Our results 
showed that almost in the 70  % of the cases (73  % for 
BEN, 72.5  % for ATP and 70  % for PLP), Geomfinder 
found 3D patterns located in the BEN/ATP/PLP binding 
sites exhibiting GScore values higher than 50 %. For com-
parative purposes, we measured the sequence compo-
nent similarity of the same pairs of proteins. In this case, 
to make a fair comparison, only the residues located up 
to 5 Å from the ligands (i.e. those lining the BEN/ATP/
PLP binding sites) were considered. Thus, the sequence 
component similarity of each pair of proteins was cal-
culated as the percentage of similar residues occurring 
in both binding sites. Interestingly, these values were in 
most cases lower than those detected by Geomfinder 
(Figs.  6, 7, 8). As previously mentioned, the sequence 
identity in two proteins does not necessarily imply that 
Fig. 4 Similarity of the sequence and the 3D patterns in the Monoamine Oxidase B proteins. The red bars represent the highest value of a GScore 
between each pair of 3D patterns related with MAO‑B binding sites. The sequence similarity between each pair of MAO proteins is shown in the 
purple bars. The blue and green bars show the similarity measured by the PocketMatch and the Click software, respectively. All pair of MAO proteins 
evaluated together with the % of similarity of all methods, are described in the X axis. The protein sequences were obtained with the babel soft‑
ware, using as input the structures obtained from the PDB database
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the spatial organization of the amino acids in each pro-
tein site is preserved. Therefore, it is not surprising that 
Geomfinder (which determines 3D similarities) per-
formed better than a sequence-based method regard-
ing the identification of similar 3D patterns in two given 
protein structures. Indeed, Geomfinder identified a high 
degree of similarity between protein 3D patterns show-
ing low sequence identity (Figs.  6, 7, 8), which implies 
that the residues forming the 3D patterns exhibit Dist, 
NbA and/or TSP parameter values, that allow to identify 
them as similar. Thus, this is an important case of evalu-
ation since the similar 3D patterns found by Geomfinder 
might underlie the binding properties of the ligands 
analyzed (BEN, ATP, PLP) to structurally unrelated pro-
teins, and also show that the software is able to identify 




We compared the crystal structures of the protein phos-
phatidyl-inositol 4,5-bisphosphate 3-kinase [PDBid: 
1E8W] (961 residues) with the oncogene serine/threo-
nine protein kinase [PDBid: 2O3P] (293 residues). These 
proteins are very dissimilar and have only 8  % of iden-
tity in their primary sequences. The sequence alignment 
yielded a similarity of 34.3  % with almost 350 residues 
aligned (including gaps). In our analysis, the initial radius 
of the distance used to build the virtual grid of coordi-
nates was set in 10 Å. Herewith, 4535 and 14,702 virtual 
Fig. 5 Similarity of the sequence and the 3D patterns in the ACR binding proteins. The red bars represent the highest value of a GScore between 
each pair of 3D patterns related with ACR binding sites. The blue and green bars show the similarity measured by the PocketMatch and the Click 
software, respectively. All pair of MAO proteins evaluated together with the % of similarity of all methods, are described in the X axis
Table 1 Evaluation of the ACR binding site similarities in 1AGM, 3AIC, 1ULV and 3WEM proteins
ACR GScore Smith ProBIS MultiBind SiteEngine
Binding Site Geomfinder (%) Waterman Pairwise Server Server
Similarity [48] (%) [25] [51] [52]
1AGM Alig. Score 33,8856 4279,01
vs 34 32 −3,63 6 same AA 1 same AA
3AIC of 19 of 13
1ULV 34,2356 4307,17
vs 25 39 Invalid 3 same AA 1 same AA
3WEM PDB: 3WEM of 13 of 13
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coordinates of reference were created into the protein 
structures of 2O3P and 1E8W respectively (see an exam-
ple in the Table  2). This generated more than 66 mil-
lion of pairs of 3D patterns, which were compared in 5 
minutes and 20 seconds. Our results revealed the exist-
ence of several pairs of 3D patterns with a GScore higher 
than 50  %, one of which corresponds to the flavonoid 
quercetin binding site. This is in agreement with a previ-
ous report [55], which showed similar chemical interac-
tions between quercetin and the residues of the binding 
site in both proteins. Among the highest GScore found, 
five pairs of these similar patterns were shown to con-
tain residues located near to the co-crystallized ligands 
quercetin and imidazole, another common ligand. Inter-
estingly, two other non-obvious similar 3D patterns were 
detected (Fig. 9). In fact, one of these pairs exhibited the 
highest GScore value (86.3  %) determined after com-
parison of both proteins. The patterns in this pair were 
detected from the virtual reference coordinate Atom459 
(in 1E8W) and Atom151 (in 2O3P), and showed values of 
100 % of similarity for the non-bonded energies (SNbE) 
and the sequence component (SSc) parameters. It should 
be noted that in order to align the sequences of these 
3D patterns (ASP637, PRO671, SER636, GLU638 and 
ARG641 to the Atom459, and ASP114, PRO113, SER115, 
GLU70 and ARG112 to Atom151), a sequence-based 
method must incorporate at least 40 gaps, with the cor-
responding decrease of the alignment significance.
Negative case
We compared the structures of the intracellular apoferri-
tin protein from Equus caballus [PDBid: 3U90] (174 resi-
dues) with the major birch pollen allergen Bet v1 protein 
from Betula pendula [PDBid: 4QIP] (159 residues). Both 
proteins have been co-crystallized with sodium dode-
cyl sulfate (SDS) and share a 35 % of their amino acids 
sequences. In our tests, Geomfinder did not find simi-
lar 3D patterns corresponding to their SDS binding sites. 
This result indicates that even though both proteins 
share a common ligand, the binding sites and the bind-
ing mode of SDS at these sites are not similar. Neverthe-
less, Geomfinder identified some similar 3D patterns in 
both proteins. Thus, the best GScore (67,7  %) detected 
patterns defined from the virtual reference Atom1043 
(3U90) and Atom2088 (4QIP). Interestingly, the 3D pat-
tern denoted by the virtual reference Atom2088 (4QIP) 
was located in the SDS binding site whereas the 3D pat-
tern defined by the virtual reference Atom1043 (3U90) 
Fig. 6 Similarity of the 3D patterns in the Benzamidine (BEN) binding proteins. In red is represented the higher value of the GScore (Geomfinder) 
between each pair of 3D patterns related with the BEN binding sites. The Sequence Component Similarity between each pair of BEN target proteins 
is shown in blue. All pair of the evaluated proteins are described in this scatter plot
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was located in an extracellular zone of the protein 
(Fig. 10). After an evaluation with the software MetaPoc-
ket [56], a possible ligand-binding site was identified in 
the same zone that was defined by the virtual reference 
Atom1043 in the protein 3U90 (residues ALA14 and 
ALA15; Additional file 1: Figure S2). This result suggests 
that these proteins might still share a similar binding 
site, and could interact with some currently unknown 
common ligands.
Uncommon case
In an additional evaluation, we analyzed the crystal 
structure of the human monoamine oxidase A (MAO-
A) [PDBid: 2BXS] co-crystallized with the selective and 
irreversible inhibitor clorgiline (MLG), and a homology 
model of the human serotonin transporter (SERT), built 
using the structure of the Drosophila melanogaster dopa-
mine transporter (DAT) [PDBid: 4M48], as template. It 
has been shown that two putative ligand binding sites 
exist in SERT, named S1 and S2 [57–59], whereas a single 
substrate binding site is found in MAO-A [47]. Both pro-
teins are considerably different from a structural point of 
view, and while SERT is a transmembrane protein belong-
ing to SLC6 family, MAO-A is an outer mitochondrial 
membrane bound flavoprotein, with the FAD cofactor 
covalently bound to the enzyme. Their global sequence 
identity is only of 3.9  % while the local sequence simi-
larity shows a 34  % in a segment of 55 aligned residues 
including 19 gaps. Nevertheless, the neurotransmitter 
serotonin (5-HT) is a common ligand and the physiologi-
cal actions of both proteins are related with the regula-
tion of adequate levels of 5-HT in the synaptic cleft. In 
spite of the low sequence similarity, Geomfinder was able 
to detect several similar 3D patterns between SERT y 
MAO-A, one of which correspond to the MLG binding 
site in MAO-A and the binding site S2 of SERT. These 3D 
patterns, defined by the virtual reference Atom1393 (in 
MAO-A) and Atom12422 (in SERT), have a GScore value 
of 100  % (Fig.  11). We designated this case as “uncom-
mon” since it shows that Geomfinder is able to find iden-
tical 3D patterns in binding sites belonging to proteins 
with highly different sequences, structures, genetic ori-
gin, tissue distribution and catalytic activities. In this par-
ticular case, SERT and MAO-A similarities found suggest 
Fig. 7 Similarity of the 3D patterns in the Adenosite Triphosphate (ATP) binding proteins. In red is represented the higher value of the GScore 
(Geomfinder) between each pair of 3D patterns related with the ATP binding sites. The Sequence Component Similarity between each pair of ATP 
target proteins is shown in blue. All pair of the evaluated proteins are described in this scatter plot
Page 11 of 15Núñez‑Vivanco et al. J Cheminform  (2016) 8:19 
the existence of some degree of structural convergence 
between both proteins, which could be related with the 
recognition of the common substrate.
Conclusions
Geomfinder is a an intuitive, flexible and alignment-free 
web server to detect all similar 3D patterns between any 
Fig. 8 Similarity of the 3D patterns in the Pyridoxal Phosphate (PLP) binding proteins. In red is represented the higher value of the GScore (Geom‑
finder) between each pair of 3D patterns related with the PLP binding sites. The Sequence Component Similarity between each pair of PLP target 
proteins is shown in blue. All pair of the evaluated proteins are described in this scatter plot
Fig. 9 Score values for similar pairs of 3D patterns detected in 1E8W and 2O3P. In this figure, eight pairs of similar 3D patterns are shown. The 3D 
patterns corresponding to the quercetin binding sites are shown in green. The 3D patterns whose residues are located near of the quercetin and 
imidazole binding sites, are shown in pink. The 2 non‑obvious similar 3D patterns found, are shown in yellow. In the red box, are shown the final 
similarity scores of Geomfinder (GScore)
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pairs of protein structures, which can come from both, 
X-ray experiments or homology models. The similarity 
score of Geomfinder (GScore) is calculated as the sum of 
the relative contribution of the partial similarities of dif-
ferent features of the 3D patterns, such as distance, non-
bonded energy, sequence-component similarity and the 
perimeter. The latter had not been used thus far by the 
current available structured-based methods that meas-
ure local structural similarities, and represents an effi-
cient inclusion of an algorithm commonly used in areas 
such as transport, business and logistics applications, into 
a biochemical context. Several examples were analyzed 
and millions of measurements in almost 1100 protein 
structures were done. Our results confirm the sensitivity 
of Geomfinder to detect all similar 3D pattern related to 
the binding sites of MAO-B, even in those cases where the 
structure of ligands were highly different. The assessment 
of protein targets of ACR, PLP, BEN and ATP, revealed 
the relevance of finding partial similarities at structural 
level, which is unaffected by the natural divergence of the 
amino acids sequences. In addition, the detailed evalua-
tion of three specific cases was described. These analyses 
showed the versatility of Geomfinder which was able to 
discriminate between similar and different 3D patterns 
related to binding sites of common substrates in a range 
of diverse proteins. Remarkably, Geomfinder detected 
identical 3D patterns associated to the binding sites of a 
common substrate in two fylogenetically distant proteins 
such as SERT and MAO-A. In this context, our software 
can be useful for determining potential druggable sites 
in unrelated proteins, which is a primary input for the 
structure-based rational design of drugs with a polyp-
harmacological profile. Interestingly, as our approach is 
ligand-independent, the similar 3D patterns identified by 
Geomfinder could represent unanticipated ligand binding 
sites that might be associated to very different functions 
in each protein. This gives an unusual opportunity for 
exploring the chemical space in the search of molecules 
that could fit and interact at these cavities. For instance, 
one can envision novel pharmacological properties for a 
compound simultaneously affecting the activity of two 
proteins if it binds to an allosteric site in one target and 
disrupts protein interactions in the other one. In addition, 
based on the occurrence of 3D pattern similarities and the 
Fig. 10 Similar 3D patterns between 4QIP and 3U90. 4QIP and 3U90 
proteins are depicted in gray and brown respectively. SDS is shown 
in yellow and circles indicate the most similar pairs of 3D patterns 
detected
Fig. 11 Similar 3D patterns between MAO‑A and SERT. The binding 
sites in SERT (S1 and S2) and MAO‑A (MLG) are depicted in red. The 
circles represent the identical 3D pattern detected by Geomfinder
Table 2 Virtual Coordinates of  Reference. Amount of  vir-
tual coordinates of  reference in  relation with  the Grid 
















Page 13 of 15Núñez‑Vivanco et al. J Cheminform  (2016) 8:19 
possible existence of similarities between more than two 
structural motifs, the results of Geomfinder help to unveil 
more subtle connections between proteins, and therefore 
be useful for novel procedures of protein classification. 
Thus, for instance, a group of proteins classified as func-
tionally related on the basis of a similar catalytic activity, 
might be further sub clustered if the similarities between 
other 3D patterns are considered.
Even though in most of the cases analyzed, Geomfinder 
exhibited a better/similar performance when compared 
to other tools, it should be stressed that an exhaustive 
benchmarking was not intended, since our software 
executes a type of analysis that differs from those car-
ried out by other available programs. Thus, the ability of 
Geomfinder to detect a higher number of pairs of pro-
teins with similar 3D patterns associated to the binding 
of a common ligand (e.g. the case of ACR), seems to be 
more related to a conceptual difference rather than a bet-
ter technical performance. In this context, the identifica-
tion and comparison of 3D patterns, which are usually 
smaller than the whole cavitiy defining a binding site, can 
reveal similarities that are not detected by current ligand-
dependent or independent algorithms which align the 
most similar three-dimensional substructure between a 
pair of protein structures [25, 49].
 Finally, it should be noted that Geomfinder is not 
intended for simultaneous multiple comparisons in a 
large number or families of proteins. However, it can be 
particularly useful in cases such as the structure-based 
design of multitarget drugs, where a detailed analysis of 




Project home page: Geomfinder can be executed in 
http://appsbio.utalca.cl/geomfinder/. The source files of 
the entire Proyect is freely and anonymously available in 
the following Bitbucket repository: https://bitbucket.org/
gnunezv/geomfinder
Operating system(s): Platform independent
Programming language: Python, JavaScript, PHP, HTML.
Other requirements: The web-browser must have the 
Java Plugin activated.
License: GNU GPL.
Any restrictions to use by non-academics: Formal 
authorization by the authors is needed for commercial 
use of Geomfinder.
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